Park Place Capital Corp Has $57,000 Position in CVS Health Corporation $CVS

Park Place Capital Corp decreased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 45.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 813 shares of the pharmacy operator’s stock after selling 683 shares during the period. Park Place Capital Corp’s holdings in CVS Health were worth $57,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Poinciana Advisors Group LLC raised its holdings in CVS Health by 51.1% during the second quarter. Poinciana Advisors Group LLC now owns 5,036 shares of the pharmacy operator’s stock worth $347,000 after buying an additional 1,704 shares during the last quarter. Centennial Wealth Advisory LLC acquired a new position in CVS Health during the second quarter worth $519,000. GC Wealth Management RIA LLC raised its holdings in CVS Health by 34.3% during the second quarter. GC Wealth Management RIA LLC now owns 9,053 shares of the pharmacy operator’s stock worth $624,000 after buying an additional 2,312 shares during the last quarter. Sound Income Strategies LLC raised its holdings in CVS Health by 32.3% during the second quarter. Sound Income Strategies LLC now owns 2,774 shares of the pharmacy operator’s stock worth $191,000 after buying an additional 677 shares during the last quarter. Finally, Smith Salley Wealth Management raised its holdings in CVS Health by 3.2% during the second quarter. Smith Salley Wealth Management now owns 9,002 shares of the pharmacy operator’s stock worth $621,000 after buying an additional 275 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. UBS Group upgraded shares of CVS Health from a “neutral” rating to a “buy” rating and upped their target price for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Morgan Stanley upped their target price on shares of CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Wolfe Research upped their target price on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Finally, Cowen reiterated a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $78.25.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.22% of the stock is currently owned by company insiders.

CVS Health Price Performance

CVS opened at $75.31 on Wednesday. The firm has a market cap of $95.52 billion, a P/E ratio of 21.04, a PEG ratio of 0.83 and a beta of 0.62. The firm has a 50-day moving average of $69.70 and a 200 day moving average of $67.13. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $77.34.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s dividend payout ratio is 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.